TNF alpha (TNF) rabbit polyclonal antibody, Aff - Purified
Applications | IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
Immunogen | Synthetic peptide corresponding to amino acids 141-190 of Human TNF-α. |
TNF alpha (TNF) rabbit polyclonal antibody, Aff - Purified
Applications | IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
Immunogen | Synthetic peptide corresponding to amino acids 141-190 of Human TNF-α. |
TNF rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human TNF |
TNF rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human TNF |
Rabbit polyclonal anti-TNFA antibody
Applications | IF, IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized peptide derived from internal of human TNFA. |
TNF rabbit polyclonal antibody, Serum
Applications | IHC, R, WB |
Reactivities | Bovine |
Immunogen | Recombinant Bovine Tumor Necrosis Factor alpha (TNF alpha) |
TNF rabbit polyclonal antibody, Serum
Applications | IHC, R, WB |
Reactivities | Bovine |
Immunogen | Recombinant Bovine Tumor Necrosis Factor alpha (TNF alpha) |
Rabbit Polyclonal TNFA Antibody
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against A synthesized peptide derived from human TNFA |
Biotinylated Anti-Rat TNF-a Rabbit Polyclonal Antibody
Applications | ELISA |
Reactivities | Rat |
Immunogen | E.coli derived Recombinant Rat TNF-α |
Rabbit polyclonal TNF Alpha antibody
Applications | IHC, WB |
Reactivities | Human, Primate |
Conjugation | Unconjugated |
Immunogen | The whole rabbit serum was prepared by repeated immunizations with recombinant human TNFa produced in E.coli. |
Rabbit polyclonal TNF alpha antibody
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The whole rabbit serum used to produce this IgG fraction antibody was prepared by repeated immunizations with recombinant human TNFa produced in E.coli. |
Anti-Human TNF-a Rabbit Polyclonal Antibody
Applications | ELISA, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | E.coli derived Recombinant Human TNF-α |
Rabbit Polyclonal TNF-alpha Antibody
Applications | IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | A synthetic peptide made to an internal portion of the human TNF alpha protein (between residues 100-200) [UniProt P01375] |
Tnf rabbit polyclonal antibody, Purified
Applications | WB |
Reactivities | Mouse |
Immunogen | Highly pure (> 95%) recombinant Mouse TNF-alpha (Leu80-Leu235) derived from E. coli. |
Tnf rabbit polyclonal antibody, Purified
Applications | WB |
Reactivities | Mouse |
Immunogen | Highly pure (> 95%) recombinant Mouse TNF-alpha (Leu80-Leu235) derived from E. coli. |
Biotinylated Anti-Human TNF-a Rabbit Polyclonal Antibody
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | E.coli derived Recombinant Human TNF-α |
Anti-Rat TNF-a Rabbit Polyclonal Antibody
Applications | ELISA |
Reactivities | Rat |
Immunogen | E.coli derived Recombinant Rat TNF-α |
Rabbit Polyclonal Anti-TNF-alpha Antibody
Reactivities | Rat |
Immunogen | For immunization recombinant rat TNF-alpha (E.coli-derived) is used |
Rabbit Polyclonal Anti-TNF-alpha Antibody, Biotin conjugated
Reactivities | Rat |
Immunogen | For immunization recombinant rat TNF-alpha (E.coli-derived) is used |
Rabbit Polyclonal Anti-TNF-alpha Antibody
Reactivities | Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | For immunization recombinant mouse TNF-alpha (E.coli-derived) is used |
Rabbit Polyclonal Anti-TNF-alpha Antibody, Biotin conjugated
Reactivities | Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | For immunization recombinant mouse TNF-alpha (E.coli-derived) is used |
Anti-TNF Rabbit Polyclonal Antibody
Applications | IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Fusion protein corresponding to a region derived from 57-233 amino acids of human tumor necrosis factor |
TNF rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human TNF |
TNF-α Rabbit polyclonal Antibody
Applications | IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | A synthetic peptide of human TNF |
Modifications | Unmodified |
TNF alpha Rabbit polyclonal Antibody
Applications | ELISA, IHC, WB |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized peptide derived from the Internal region of human TNF. AA range:151-200 |
TNF alpha Rabbit polyclonal Antibody
Applications | ELISA, IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized peptide derived from human TNFA. AA range:141-190 |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |